Synthesis and In Vitro Antibacterial Activity of 7-(3-Amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c] Pyridin-5(4H)-yl)fluoroquinolone Derivatives
A series of novel 7-(3-amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c]pyridin- 5(4H)-yl)fluoroquinolone derivatives were designed, synthesized and characterized by 1H-NMR, MS and HRMS. These fluoroquinolones were evaluated for their in vitro antibacterial activity against representative Gram-positive...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2011-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/16/3/2626/ |
id |
doaj-c84557b6a8e0411483f70e8e3f50b503 |
---|---|
record_format |
Article |
spelling |
doaj-c84557b6a8e0411483f70e8e3f50b5032020-11-24T20:43:09ZengMDPI AGMolecules1420-30492011-03-011632626263510.3390/molecules16032626Synthesis and In Vitro Antibacterial Activity of 7-(3-Amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c] Pyridin-5(4H)-yl)fluoroquinolone DerivativesJu Xian WangHui Yuan GuoXin GuoMing Liang LiuYu Cheng WangA series of novel 7-(3-amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c]pyridin- 5(4H)-yl)fluoroquinolone derivatives were designed, synthesized and characterized by 1H-NMR, MS and HRMS. These fluoroquinolones were evaluated for their in vitro antibacterial activity against representative Gram-positive and Gram-negative strains. Results reveal that most of the target compounds exhibit good growth inhibitory potency against methicillin-resistant Staphylococcus epidermidis (MRSE) (MIC: 0.25–4 μg/mL) and Streptococcus pneumoniae (MIC: 0.25–1 μg/mL). In addition, compound 8f is 8–128 fold more potent than the reference drugs gemifloxacin (GM), moxifloxacin (MX), ciprofloxacin (CP) and levofloxacin (LV) against methicillin-resistant Staphylococcus aureus 10-05 and Streptococcus hemolyticus 1002 and 2–64 fold more active against methicillin-sensitive Staphylococcus aureus 10-03 and 10-04. http://www.mdpi.com/1420-3049/16/3/2626/fluoroquinoloneantibacterial activitysynthesis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ju Xian Wang Hui Yuan Guo Xin Guo Ming Liang Liu Yu Cheng Wang |
spellingShingle |
Ju Xian Wang Hui Yuan Guo Xin Guo Ming Liang Liu Yu Cheng Wang Synthesis and In Vitro Antibacterial Activity of 7-(3-Amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c] Pyridin-5(4H)-yl)fluoroquinolone Derivatives Molecules fluoroquinolone antibacterial activity synthesis |
author_facet |
Ju Xian Wang Hui Yuan Guo Xin Guo Ming Liang Liu Yu Cheng Wang |
author_sort |
Ju Xian Wang |
title |
Synthesis and In Vitro Antibacterial Activity of 7-(3-Amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c] Pyridin-5(4H)-yl)fluoroquinolone Derivatives |
title_short |
Synthesis and In Vitro Antibacterial Activity of 7-(3-Amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c] Pyridin-5(4H)-yl)fluoroquinolone Derivatives |
title_full |
Synthesis and In Vitro Antibacterial Activity of 7-(3-Amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c] Pyridin-5(4H)-yl)fluoroquinolone Derivatives |
title_fullStr |
Synthesis and In Vitro Antibacterial Activity of 7-(3-Amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c] Pyridin-5(4H)-yl)fluoroquinolone Derivatives |
title_full_unstemmed |
Synthesis and In Vitro Antibacterial Activity of 7-(3-Amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c] Pyridin-5(4H)-yl)fluoroquinolone Derivatives |
title_sort |
synthesis and in vitro antibacterial activity of 7-(3-amino-6,7-dihydro-2-methyl-2h-pyrazolo[4,3-c] pyridin-5(4h)-yl)fluoroquinolone derivatives |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2011-03-01 |
description |
A series of novel 7-(3-amino-6,7-dihydro-2-methyl-2H-pyrazolo[4,3-c]pyridin- 5(4H)-yl)fluoroquinolone derivatives were designed, synthesized and characterized by 1H-NMR, MS and HRMS. These fluoroquinolones were evaluated for their in vitro antibacterial activity against representative Gram-positive and Gram-negative strains. Results reveal that most of the target compounds exhibit good growth inhibitory potency against methicillin-resistant Staphylococcus epidermidis (MRSE) (MIC: 0.25–4 μg/mL) and Streptococcus pneumoniae (MIC: 0.25–1 μg/mL). In addition, compound 8f is 8–128 fold more potent than the reference drugs gemifloxacin (GM), moxifloxacin (MX), ciprofloxacin (CP) and levofloxacin (LV) against methicillin-resistant Staphylococcus aureus 10-05 and Streptococcus hemolyticus 1002 and 2–64 fold more active against methicillin-sensitive Staphylococcus aureus 10-03 and 10-04. |
topic |
fluoroquinolone antibacterial activity synthesis |
url |
http://www.mdpi.com/1420-3049/16/3/2626/ |
work_keys_str_mv |
AT juxianwang synthesisandinvitroantibacterialactivityof73amino67dihydro2methyl2hpyrazolo43cpyridin54hylfluoroquinolonederivatives AT huiyuanguo synthesisandinvitroantibacterialactivityof73amino67dihydro2methyl2hpyrazolo43cpyridin54hylfluoroquinolonederivatives AT xinguo synthesisandinvitroantibacterialactivityof73amino67dihydro2methyl2hpyrazolo43cpyridin54hylfluoroquinolonederivatives AT mingliangliu synthesisandinvitroantibacterialactivityof73amino67dihydro2methyl2hpyrazolo43cpyridin54hylfluoroquinolonederivatives AT yuchengwang synthesisandinvitroantibacterialactivityof73amino67dihydro2methyl2hpyrazolo43cpyridin54hylfluoroquinolonederivatives |
_version_ |
1716820374970171392 |